Which component is NOT part of the evaluation process for a BTT device?

The evaluation process for a Biventricular Temporary Transplant (BTT) device is comprehensive, focusing on several critical components to ensure patient candidacy and safety. Monitoring blood pressure is an important aspect of overall patient care, particularly in cardiac patients, but it does not specifically pertain to the evaluation of candidacy for a BTT device.

Assessment of right heart function is crucial, as understanding the dynamics of both the left and right sides of the heart ensures that the BTT can adequately support the patient. Psychosocial assessment is another vital component because it evaluates the patient’s mental and emotional readiness for such an invasive procedure, addressing factors that may impact rehabilitation and adherence to post-transplant care. Lastly, evaluating extra cardiac organ systems is necessary to assess the overall health and functionality of other organs that could influence recovery and the success of the device.

In summary, while blood pressure monitoring is an essential clinical practice, it is not a specific evaluative component in the context of determining a patient’s eligibility for a BTT device.